These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17473441)

  • 1. Comparison of pharmacokinetics of individual teicoplanin components in patients.
    Hanada K; Ikari S; Koukaki Y; Utena A; Kimura T; Hamano K; Ariki H; Masuhara K; Ogata H
    Biol Pharm Bull; 2007 May; 30(5):952-4. PubMed ID: 17473441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved quantitative determination of total and unbound concentrations of six teicoplanin components in human plasma by high performance liquid chromatography.
    Hanada K; Kobayashi A; Okamori Y; Kimura T; Ogata H
    Biol Pharm Bull; 2005 Oct; 28(10):2023-5. PubMed ID: 16204971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancy.
    Byrne CJ; Parton T; McWhinney B; Fennell JP; O'Byrne P; Deasy E; Egan S; Enright H; Desmond R; Ryder SA; D'Arcy DM; McHugh J; Roberts JA
    J Antimicrob Chemother; 2018 Apr; 73(4):995-1003. PubMed ID: 29272419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in Trough Total and Unbound Teicoplanin Concentrations and Achievement of Therapeutic Drug Monitoring Targets in Adult Patients with Hematological Malignancy.
    Byrne CJ; Roberts JA; McWhinney B; Fennell JP; O'Byrne P; Deasy E; Egan S; Desmond R; Enright H; Ryder SA; D'Arcy DM; McHugh J
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic/pharmacodynamic targets in adult patients with haematological malignancy.
    Byrne CJ; Roberts JA; McWhinney B; Ryder SA; Fennell JP; O'Byrne P; Deasy E; Egan S; Desmond R; Enright H; D'Arcy DM; McHugh J
    Clin Microbiol Infect; 2017 Sep; 23(9):674.e7-674.e13. PubMed ID: 28267636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of arterio-venous haemofiltration on teicoplanin elimination.
    Hillaire-Buys D; Peyriere H; Lobjoie E; Bres J; Ossart M; Despaux E
    Br J Clin Pharmacol; 1995 Jul; 40(1):95-7. PubMed ID: 8527277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin concentration significantly impacts on free teicoplanin plasma concentrations in non-critically ill patients with chronic bone sepsis.
    Brink AJ; Richards GA; Lautenbach EE; Rapeport N; Schillack V; van Niekerk L; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2015 Jun; 45(6):647-51. PubMed ID: 25819167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of individual components of teicoplanin in man.
    Bernareggi A; Danese A; Cometti A; Buniva G; Rowland M
    J Pharmacokinet Biopharm; 1990 Dec; 18(6):525-43. PubMed ID: 2149149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of teicoplanin in hospitalized elderly patients using cystatin C as an indicator of renal function.
    Kasai H; Tsuji Y; Hiraki Y; Tsuruyama M; To H; Yamamoto Y
    J Infect Chemother; 2018 Apr; 24(4):284-291. PubMed ID: 29292178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of arteriovenous hemofiltration on teicoplanin pharmacokinetics].
    Choufane S; Lobjoie E; Tinturier F
    Ann Fr Anesth Reanim; 1996; 15(8):1168-72. PubMed ID: 9636789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of teicoplanin in critically ill patients undergoing continuous hemodiafiltration.
    Yagasaki K; Gando S; Matsuda N; Kameue T; Ishitani T; Hirano T; Iseki K
    Intensive Care Med; 2003 Nov; 29(11):2094-5. PubMed ID: 14504724
    [No Abstract]   [Full Text] [Related]  

  • 12. Teicoplanin binding in plasma following administration of increasing intravenous doses to healthy volunteers.
    Bernareggi A; Borgonovi M; Del Favero A; Rosina R; Gavanaghi L
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():256-60. PubMed ID: 1840325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetics of Unbound and Total Teicoplanin in Critically Ill Pediatric Patients.
    Aulin LBS; De Paepe P; Dhont E; de Jaeger A; Vande Walle J; Vandenberghe W; McWhinney BC; Ungerer JPJ; van Hasselt JGC; De Cock PAJG
    Clin Pharmacokinet; 2021 Mar; 60(3):353-363. PubMed ID: 33030704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of teicoplanin in human plasma and urine by affinity and reversed-phase high-performance liquid chromatography.
    Riva E; Ferry N; Cometti A; Cuisinaud G; Gallo GG; Sassard J
    J Chromatogr; 1987 Oct; 421(1):99-110. PubMed ID: 2963015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teicoplanin pharmacokinetics in critically ill paediatric patients.
    Sánchez A; López-Herce J; Cueto E; Carrillo A; Moral R
    J Antimicrob Chemother; 1999 Sep; 44(3):407-9. PubMed ID: 10511412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Pharmacokinetics and Pharmacodynamics of Teicoplanin and C-Reactive Protein in Hospitalized Patients With Gram-Positive Infections.
    Ogami C; Tsuji Y; Muraki Y; Mizoguchi A; Okuda M; To H
    Clin Pharmacol Drug Dev; 2020 Feb; 9(2):175-188. PubMed ID: 30934169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors on trough teicoplanin levels, associations between levels, efficacy and safety in patients with gram-positive infections.
    Wang T; Li N; Hu S; Xie J; Lei J; Wang Y; Zheng X; Xing J; Dong Y
    Int J Clin Pharmacol Ther; 2015 May; 53(5):356-62. PubMed ID: 25828639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and tonsillar tissue pharmacokinetics of teicoplanin following intramuscular administration to children.
    Aarons L; Rowland M; Khan A; Taborelli G; Ferrea G; Tarantino V; Fioredda F; Rosina-Parenti R; Cavenaghi L; Borgonovi M
    Eur J Pharm Sci; 1998 Oct; 6(4):265-70. PubMed ID: 9795079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in teicoplanin protein binding and its prediction using serum albumin concentrations.
    Yano R; Nakamura T; Tsukamoto H; Igarashi T; Goto N; Wakiya Y; Masada M
    Ther Drug Monit; 2007 Aug; 29(4):399-403. PubMed ID: 17667792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic-pharmacodynamic aspects of antimicrobial prophylaxis with teicoplanin in patients undergoing major vascular surgery.
    Pea F; Furlanut M; Stellini R; Bonardelli S; Signorini L; Pavan F; Matheis A; Portolani N; Lorenzotti S; Giulini SM; Viale P; Carosi G
    Int J Antimicrob Agents; 2006 Jan; 27(1):15-9. PubMed ID: 16343858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.